- 46.1k views
Approach To Portal Hypertension
Portal hypertension is a clinical syndrome defined by a hepatic vein pressure gradient (HVPG) greater than 5 mm Hg, and is associated with encephalopathy, ascites, splenomegaly, and gastrointestinal varices. In individuals with cirrhosis, portal hypertension is the primary cause of serious complications and death. Noncirrhotic portal hypertension (NCPH), a disease where portal hypertension develops even in the absence of cirrhosis, is another possibility. The objective is to identify and describe the severity of portal hypertension in both NCPH and cirrhotic portal hypertension. However, knowledge of the underlying pathophysiological and etiological characteristics is crucial for understanding portal hypertension diagnosis and treatment.
About the Speaker
Dr. Rajat Bansal
Consultant Gastroenterologist and Therapeutic Endoscopist at Indraprastha Apollo Hospital, New Delhi.
Dr. Rajat Bansal is a Consultant Gastroenterologist and Therapeutic Endoscopist at Indraprastha Apollo Hospital, New Delhi.
Upcoming Case Discussions
Hepatic Regeneration After Hepatectomy
Hepatic regeneration after hepatectomy is a dynamic process where the liver rapidly repairs and regenerates its tissue by activating hepatocytes and liver progenitor cells. This regenerative ability is essential for restoring liver function and maintaining homeostasis following partial liver resection or injury.
Fluorescence Guided Breast Cancer Surgery
Fluorescence-guided breast cancer surgery uses fluorescent dyes, such as indocyanine green (ICG), to illuminate cancerous tissues and lymph nodes, aiding surgeons in precisely identifying and removing tumors. This technique improves surgical outcomes by enhancing the visualization of cancerous areas, reducing the chances of leaving residual cancer cells behind.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Rajat Bansal's Talks on Assimilate
- 9th-July-2024, TIME : 6:00PM TO 7:00 PM
- 0
Portal hypertension is a clinical syndrome defined by a hepatic vein pressure gradient (HVPG) greater than 5 mm Hg, and is associated with encephalopathy, ascites, splenomegaly, and gastrointestinal varices. In individuals with cirrhosis, portal hypertension is the primary cause of serious complications and death. Noncirrhotic portal hypertension (NCPH), a disease where portal hypertension develops even in the absence of cirrhosis, is another possibility. The objective is to identify and describe the severity of portal hypertension in both NCPH and cirrhotic portal hypertension. However, knowledge of the underlying pathophysiological and etiological characteristics is crucial for understanding portal hypertension diagnosis and treatment.